Accelerate safer, smarter drug discovery

Cortellis Drug Discovery Intelligence and OFF-X are built for drug discovery, preclinical and translational professionals who need a holistic, translational approach to optimize early-stage research.

Unlike fragmented alternatives, this combined solution offers broad and deep coverage of biology, pharmacology, chemistry, and toxicity data — integrated across the full drug development lifecycle.

With increasing investor pressure and flat success rates, every failed trial costs more. OFF-X and Cortellis give you the insight you need to avoid those failures and the confidence to move faster with less risk.

• OFF-X equips you to anticipate safety risks for targets and compounds, from discovery to post-market.
• Cortellis Drug Discovery Intelligence provides rich biological, pharmacological, and competitive insights to drive target selection and compound optimization.
• Together, they help reduce late-stage failures, prioritize safer, more promising targets, compare experimental data and anticipate adverse events, design smarter early-phase trials.